News
Take D-Bal, for instance. Inspired by Dianabol, it uses a blend of MSM, Ashwagandha, L-Leucine, and Suma Root to increase ...
With synthetic steroid use declining and clean performance on the rise, CrazyBulk has emerged as the trusted name in legal ...
The Anosh Inc Foundation is a nonprofit organization based in Chicago, focused on enhancing lives through programs in ...
ALK ( ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved EUR neffy® 2 mg in the United Kingdom (UK) for anaphylaxis treatment of ...
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at ...
When paired with oral legal peptides focused on recovery and muscle support, this stack becomes a dual-threat system: fat ...
Net Profit Achieved: Q2 2025 marked Hapbee’s first profitable quarter in company history, with net income of $17,988, compared to a net loss of $178,984 in Q1 2025 and a loss of $1.86 million in Q2 ...
EURneffy is the trade name for neffy® (epinephrine nasal spray) in the United Kingdom. About neffy® neffy is a nasal spray used for emergency treatment of allergic reactions including anaphylaxis, in ...
Each option was granted pursuant to the Aardvark Therapeutics, Inc. 2025 Inducement Equity Incentive Plan, and was granted as an inducement material to each employee’s employment with Aardvark in ...
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it is finalizing a significant three-year collaborative agreement ...
The stock options have a ten-year term and an exercise price of $2.38 per share, which is equal to the closing price of Vor Bio’s common stock on July 17, 2025. The stock options will vest over a four ...
This release has been authorised by the directors of Immuron Limited. Steven Lydeamore Chief Executive Officer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results